Replies to post #45 on Regeneron Pharmaceuticals Inc (REGN)

[onarun]

Did a search and this company came up...........should be $200+pps

[surf1944]

3:16AM Regeneron Pharms EYLEA injection approved for the treatment of Wet Age-Related Macular Degeneration in Europe (REGN) 174.39 : Co announces that EYLEA injection has been approved by the European Commission for the treatment of patients with neovascular age-related macular degeneration. EYLEA was approved for the treatment of neovascular AMD in the United States in November 2011 and in Japan, Australia, Switzerland, and other countries this year. Bayer HealthCare (BAYRY) plans to launch EYLEA in these countries later in 2012 and into 2013. In the United States, EYLEA was also approved for the treatment of Macular Edema following Central Retinal Vein Occlusion in September 2012